Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats

Critical Care Medicine

Volumn 27, Issue 2, 1999, Pages 356-364

  Qu, Xiao Wu ^a   Rozenfeld, Ranna A ^a   Huang, Wei ^a   Sun, Xiaoming ^a   Tan, Xiao Di ^a   Hsueh, Wei ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Intestine; Nitric oxide; Nitric oxide synthase; Platelet activating factor; Shock; Small intestine

Indexed keywords

AMINOGUANIDINE; GRANULOCYTE ANTIBODY; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LOCALIZATION; INTESTINE NECROSIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; TISSUE INJURY; TISSUE REACTION;

EID: 0032956050     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199902000-00043     Document Type: Article

References (51)

1. 1. Yamamoto R, Wada A, Asada Y, et al: Functional relation between nitric oxide and noradrenaline for the modulation of vascular tone in rat mesenteric vasculature. Naunyn-Schmiedebergs Arch Pharmacol 1994; 349:362-366
2. 2. Suzuki N, Mizuno K, Gomi Y: Role of nitric oxide in the peristalsis in the isolated guinea-pig ileum. Eur J Pharmacol 1994; 251:221-227
3. 3. Kubes P: Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992; 262: G1138-G1142
4. 4. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262:H611-H615
5. 5. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991; 88:4651-4655
6. 6. Kubes P: Ischemia-reperfusion in feline small intestine: A role for nitric oxide. Am J Physiol 1993; 264: G143-G149
7. 7. Miller MJ, Munshi UK, Sadowska-Krowicka H, et al: Inhibition of calcium-dependent nitric oxide synthase causes ileitis and leukocytosis in guinea pigs. Digest Dis Sci 1994; 39: 1185-1192
8. 8. Mackendrick W, Caplan M, Hsueh W: Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat. Pediatr Res 1993; 34:222-228
9. 9. Stuehr DJ, Nathan CF: Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169:1543-1555
10. 10. Tepperman BL, Brown JF, Whittle BJ: Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993; 265:G214-G218
11. 11. Kilbourn RG, Griffith OW: Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 1992; 84:827-831
12. 12. Boughton-Smith NK, Evans SM, Laszlo F, et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993; 110:1189-1195
13. 13. Tepperman BL, Brown JF, Korolkiewicz R, et al: Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: Effect of endotoxin challenge. J Pharmacol Exp Ther 1994; 271:1477-1482
14. 14. Kilbourn RG, Jubran A, Gross SS, et al: Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172:1132-1138
15. 15. Thiemermann C, Vane J: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat in vivo. Eur J Pharmacol 1990; 182:591-595
16. 16. Julou-Schaefer G, Gray GA, Fleming I, et al: Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990; 259:H1038-H1043
17. 17. Pastor C, Teisseire B, Vicant E, et al: Effect of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22:465-469
18. 18. Laszlo F, Evans SM, Whittle BJ: Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 1995; 272:169-175
19. 19. Szabo C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91:12472-12476
20. 20. Benveniste J: Paf-acether, an ether phospholipid with biological activity. Prog Clin Biol Res 1988; 282:73-85
21. 21. Handley DA: Platelet-activating factor as a mediator of endotoxin-related diseases. In: Platelet-Activating Factor in Endotoxin and Immune Diseases. Handley DA, Saunders RN, Houlihan WJ, et al (Eds). New York, Marcel Dekker, 1990, pp 451-495
22. 22. Hsueh W, Gonzalez-Crussi F, Arroyave JL: Platelet-activating factor: An endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1987; 1: 403-405
23. 23. Gonzalez-Crussi F, Hsueh W: Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am J Pathol 1983; 112:127-135
24. 24. Sun X, Hsueh W: Platelet-activating factor produces shock, in vivo complment activation, and tissue injury in mice. J Immunol 1991; 147:509-514
25. 25. Kamata K, Mori T, Shigenobu K, et al: Endothelium-dependent vasodilator effects of platelet activating factor on rat resistance vessels. Br J Pharmacol 1989; 98:1360-1364
26. 26. Szabó C, Wu CC, Mitchell JA, et al: Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res 1993; 73:991-999
27. 27. Arndt H, Russell JB, Kurose I, et al: Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 1993; 105:675-680
28. 28. Kurose I, Kubes P, Wolf R, et al: Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 1993; 73:164-171
29. 29. Rabinowitz SS, Lucas JJ, Gootman PM: NADPH-diaphorase activity in piglet intestinal mucosa. Cell Mol Biol Res 1995; 41:73-80
30. 30. Brown JF, Tepperman BL, Hanson PJ, et al: Differential distribution of nitric oxide synthase between cell fractions isolated from rat gastric mucosa. Biochem Biophysiol Res Commun 1992; 184:680-685
31. 31. Sun XM, Hsueh W: Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J Clin Invest 1988; 81:1328-1331
32. 32. Caplan MS, Sun XM, Hsueh W: Hypoxia causes ischemic bowel necrosis in rats: The role of platelet-activating factor (PAF-acether). Gastroenterology 1990; 99:979-986
33. 33. Eliakim R, Karmeli F, Razin E, et al: Role of platelet-activating factor in ulcerative colitis. Gastroenterology 1988; 95:1167-1172
34. 34. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90:1116-1121
35. 35. Kanwar S, Wallace JL, Befus D, et al: Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G222-G229
36. 36. Zhang C, Hsueh W, Caplan MS, et al: Platelet activating factor-induced shock and intestinal necrosis in the rat: Role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991; 19:1067-1072
37. 37. Rengasamy A, Johns RA: Inhibition of nitric oxide synthase by a superoxide generating system. J Pharmacol Exp Ther 1993; 267:1024-1027
38. 38. Griscavage JM, Hobbs AJ, Ignarro LJ: Negative modulation of nitric oxide synthase by nitric oxide and nitroso compound. Adv Pharmacol 1995; 34: 215-234
39. 39. Xie QW, Cho HJ, Calaycay J, et al: Cloning and characterization of inducible nitric oxide synthase from mouse macrophage. Science 1992; 256:225-228
40. 40. Hoffmann G, Grote J, Friedrich F, et al: The pulmonary epithelial cell line 2 as a new model for an inducible nitric oxide synthase expressing distal airway epithelial cell. Biochem Biophys Res Commun 1995; 217:575-583
41. 41. Cook HT, Bune AJ, Jansen AS, et al: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 1994; 87:179-186
42. 42. Keshav S, Lawson L, Chung LP, et al: Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J Exp Med 1990; 171:327-332
43. 43. Mulherkar R, Rao RS, Wagle AS, et al: Enhancing factor, a Paneth cell specific protein from mouse small intestines: Predicted amino acid sequence from RT-PCR amplified cDNA and its expression. Biochem Biophys Res Commun 1993; 197:1254-1263
44. 44. M'Rabet-Touil H, Blachier F, Morel M-T: Characterization and ontogenesis of nitric oxide synthase activity in pig enterocytes. FEBS Lett 1993; 331:243-247
45. 45. Salzman AL: Nitric oxide in the gut. New Horiz 1995; 3:33-46
46. 46. Weisbrodt NW, Pressley TA, Li Y-F, et al: Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol 1996, 271:G454-G460
47. 47. Hoffman RA, Zhang G, Nussler NC, et al: Constitutive expression of inducible nitric oxide synthase in the mouse ileal mucosa. Am J Physiol 1997, 272:G383-G392
48. 48. McCafferty D-M, Mudgett JS, Swain MG, et al: Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112:1022-1027
49. 49. Fujiskai J, Fujimoto K, Oohara A, et al: Roles of histamine and diamine oxidase in mucosa of rat small intestine after ischemia-reperfusion. Digest Dis Sci 1993; 38:1195-1200
50. 50. Beckman JS, Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87:1620-1624
51. 51. Sun XM, Caplan MS, Liu Y, et al: Endotoxin-resistant mice are protected from PAF-induced bowel injury and death. Role of TNF, complement activation, and endogenous PAF production. Digest Dis Sci 1995; 40:495-502